Drugs / MesoCellA-Ortho
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05081921 | Jan 2022 → Feb 2024 | osteoarthritis, knee | Jagiellonian University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MesoCellA-Ortho | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05081921 ↗ |
| Modality | Cell therapy | “in vitro expanded autologous human adipose tissue-derived mesenchymal stem/ stromal cells (AT-MSCs)” NCT05081921 ↗ |
| Route | Other | “will be intraarticularly administrated” NCT05081921 ↗ |